Risedronate and thrombocytopenia Patient Reports February 12, 2012

Risedronate Side Effects Report #5070017-5
Risedronate side effect was reported by a Physician from JAPAN on July 18, 2006. Female patient, 70 years of age, was diagnosed with osteoporosis prophylaxis, asthma  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: c-reactive protein increased, disseminated intravascular coagulation, thrombocytopenia, white blood cell count increased. Risedronate dosage: 2.5 MG, DAILY, ORAL. During the same period patient was treated with BAKUMONDOUTO, LASIX, DIGOXIN, WARFARIN, ALLOPURINOL, PROCATEROL, ONON, ISOSORBIDE DINITRATE. Patient died on 03/07/2006.

Risedronate Side Effects Report #5318501-0
Risedronate side effect was reported by a Physician from JAPAN on Apr 20, 2007. Male patient, 82 years of age, was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: haemorrhage subcutaneous, purpura, thrombocytopenia. Risedronate dosage: 2.5 MG DAILY, ORAL. During the same period patient was treated with NORVASC, ANTIHYPERTENSIVES. Patient was hospitalized. Patient recovered.

Risedronate Side Effects Report #5196419-4
Risedronate side effect was reported by a Consumer or non-health professional from SPAIN on Dec 12, 2006. Female patient, 75 years of age, was diagnosed with osteoporosis , pulmonary embolism , cardiac failure, respiratory disorder, gastric ulcer, electrolyte imbalance, cough, candidiasis and was treated with Risedronate. After drug was administered, patient experienced the following side effects: blood disorder, eosinophilic pneumonia, sepsis , thrombocytopenia. Risedronate dosage: 35 MG, 1 ONLY, ORAL. During the same period patient was treated with HIBOR, SEGURIL, TAVANIC, OMEPRAZOLE, URBASON, BOI K, CODEISAN, MYCOSTATIN. Patient was hospitalized. Patient died on 07/21/2006.

Risedronate Side Effects Report #4798355-1
Risedronate side effect was reported by a Physician from JAPAN on Oct 03, 2005. Female patient was diagnosed with osteoporosis  and was treated with Risedronate. After drug was administered, patient experienced the following side effects: thrombocytopenia. Risedronate dosage: 2.5 MG DAILY, ORAL. Patient was hospitalized. Patient recovered.